Target Name: OR2S2
NCBI ID: G56656
Review Report on OR2S2 Target / Biomarker Content of Review Report on OR2S2 Target / Biomarker
OR2S2
Other Name(s): OR2S1_HUMAN | Olfactory receptor family 2 subfamily S member 2 | Olfactory receptor OR9-3 | olfactory receptor family 2 subfamily S member 2 | olfactory receptor OR9-3 | Olfactory receptor 2S2 | OR37A | OST715

Understanding OR2S2: A Potential Drug Target and Biomarker

OR2S2 (OR2S1_HUMAN), a protein found in human placenta, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function have made it an attractive target for researchers to study and develop new treatments.

OR2S2 is a transmembrane protein that is expressed in various tissues and cells in the body. Its primary function is to regulate the intracellular signaling pathway known as the TGF-β pathway. TGF-β is a critical signaling pathway that plays a vital role in cell growth, differentiation, and survival. The TGF-β pathway is involved in the development and maintenance of tissues and organs, as well as in the regulation of cellular processes such as cell division, migration, and invasion.

OR2S2 is a key regulator of the TGF-β pathway in human placenta. It is a negative regulator of the pathway, which means that it works to inhibit the effects of TGF-β. OR2S2 helps to regulate the activity of TGF-β by interacting with its downstream target, Smad2.

Studies have shown that OR2S2 plays a crucial role in the regulation of placentary development and function. OR2S2 has been shown to regulate the growth and survival of human placenta fibroblasts, which are responsible for the production of the extracellular matrix (ECM) components that support the development of tissues and organs. OR2S2 has also been shown to regulate the production of certain proteins that are involved in the development of cancer.

OR2S2 has also been shown to be involved in the regulation of neurodegenerative diseases. Studies have shown that OR2S2 is involved in the regulation of the production of certain proteins that are involved in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. OR2S2 has also been shown to interact with certain proteins that are involved in the regulation of neurotransmitter systems, which may play a role in the regulation of mood and cognitive function.

OR2S2 has also been shown to be involved in the regulation of autoimmune disorders. Studies have shown that OR2S2 is involved in the regulation of the production of certain proteins that are involved in the development of autoimmune disorders, including rheumatoid arthritis and multiple sclerosis. OR2S2 has also been shown to interact with certain proteins that are involved in the regulation of immune responses, which may play a role in the regulation of autoimmune disorders.

Despite its potential as a drug target and biomarker, OR2S2 has not yet been fully studied. Further research is needed to fully understand its function and to develop new treatments based on its unique structure and function.

In conclusion, OR2S2 is a protein that has the potential to be a drug target and biomarker for various diseases. Its unique structure and function make it an attractive target for researchers to study and develop new treatments. Further research is needed to fully understand its function and to develop new treatments based on its unique structure and function.

Protein Name: Olfactory Receptor Family 2 Subfamily S Member 2

Functions: Odorant receptor

The "OR2S2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR2S2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR2T1 | OR2T10 | OR2T11 | OR2T12 | OR2T2 | OR2T27 | OR2T29 | OR2T3 | OR2T33 | OR2T34 | OR2T35 | OR2T4 | OR2T5 | OR2T6 | OR2T7 | OR2T8 | OR2U1P | OR2V1 | OR2V2 | OR2W1 | OR2W1-AS1 | OR2W3 | OR2W5P | OR2W6P | OR2Y1 | OR2Z1 | OR3A1 | OR3A2 | OR3A3 | OR3A4P | OR4A14P | OR4A15 | OR4A16 | OR4A17P | OR4A21P | OR4A47 | OR4A5 | OR4B1 | OR4C11 | OR4C12 | OR4C13 | OR4C15 | OR4C16 | OR4C1P | OR4C3 | OR4C45 | OR4C46 | OR4C5 | OR4C50P | OR4C6 | OR4D1 | OR4D10 | OR4D11 | OR4D2 | OR4D5 | OR4D6 | OR4D9 | OR4E2 | OR4F13P | OR4F15 | OR4F16 | OR4F17 | OR4F21 | OR4F29 | OR4F3 | OR4F4 | OR4F5 | OR4F6 | OR4G3P | OR4K1 | OR4K13 | OR4K14 | OR4K15 | OR4K17 | OR4K2 | OR4K5 | OR4K6P | OR4K7P | OR4L1 | OR4M1 | OR4M2 | OR4M2-OT1 | OR4N2 | OR4N3P | OR4N4 | OR4N5 | OR4P4 | OR4Q3 | OR4S1 | OR4S2 | OR4T1P | OR4V1P | OR4X1 | OR4X2 | OR51A1P | OR51A2 | OR51A3P | OR51A4 | OR51A6P | OR51A7